Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Show other versions (1)

Bibliographic Details
Main Authors:	Joanne M. Jeter, Lee D. Cranmer, Evan M. Hersh
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-07-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://la-press.com/ipilimumab-pharmacotherapy-in-patients-with-metastatic-melanoma-a3291

Similar Items

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
by: Joanne M. Jeter, et al.
Published: (2012-01-01)

Use of ipilimumab in the treatment of melanoma
by: Acharya UH, et al.
Published: (2013-08-01)

IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01)

Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma
by: A. A. Formozo, et al.
Published: (2021-01-01)

Ipilimumab cystic hypophysitis mimicking metastatic melanoma
by: John Wallace, BS, et al.
Published: (2018-06-01)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
by: Nethanel Asher, et al.
Published: (2020-08-01)

Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma
by: Vera Montes, et al.
Published: (2018-04-01)

Profile of ipilimumab and its role in the treatment of metastatic melanoma
by: Patel SP, et al.
Published: (2011-12-01)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
by: Della Vittoria Scarpati G, et al.
Published: (2014-02-01)

Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma
by: Umal Azmat, et al.
Published: (2016-01-01)

UNCONVENTIONAL PATTERN OF RESPONSE IN A METASTATIC MELANOMA PATIENT TREATED WITH IPILIMUMAB.
by: Francesco Spagnolo
Published: (2012-03-01)

Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma
by: Michael P. Chu, et al.
Published: (2020-06-01)

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma
by: Marco Tucci, et al.
Published: (2018-02-01)

Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma
by: Bartosz Chmielowski
Published: (2013-01-01)

Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma
by: April K.S. Salama
Published: (2013-01-01)

Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma
by: April K.S. Salama
Published: (2013-06-01)

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
by: Kristina Navrazhina, et al.
Published: (2020-06-01)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012-01-01)

Ipilimumab: Melanoma and beyond
by: Vishal Patel, et al.
Published: (2011-01-01)

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
by: Geoffrey T. Gibney, et al.
Published: (2019-03-01)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
by: John E. Mullinax, et al.
Published: (2018-03-01)

Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease
by: Cavalcante L, et al.
Published: (2015-01-01)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
by: Ascierto Paolo A, et al.
Published: (2012-05-01)

Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
by: D. E. Meyers, et al.
Published: (2018-03-01)

Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma
by: Matthew J. Rabinowitz, et al.
Published: (2021-01-01)

Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
by: Vidhya Karivedu, et al.
Published: (2019-01-01)

Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma
by: Wei Guoqing, et al.
Published: (2012-03-01)

The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
by: James Larkin, et al.
Published: (2015-01-01)

Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
by: Charles Ferte, et al.
Published: (2020-07-01)

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
by: Anders H. Kverneland, et al.
Published: (2018-05-01)

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient
by: Alfredo Addeo, et al.
Published: (2013-05-01)

Ipilimumab-Induced Neutropenia in Melanoma
by: Makiko Ban-Hoefen MD, et al.
Published: (2016-08-01)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
by: Vidhya Karivedu, et al.
Published: (2019-01-01)

Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy
by: Saaya Yoshida, et al.
Published: (2019-10-01)

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
by: Lisa Zimmer, et al.
Published: (2015-01-01)

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment
by: Wang Wenshi, et al.
Published: (2012-07-01)

In vivo Confocal Microscopy in Differentiating Ipilimumab-Induced Anterior Uveitis from Metastatic Uveal Melanoma
by: Hayyam Kiratli, et al.
Published: (2016-09-01)

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
by: Marin A. McDonald, et al.
Published: (2018-05-01)

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
by: Hansoo Kim, et al.
Published: (2018-02-01)

A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab
by: Daniel J Olson, et al.
Published: (2020-06-01)